Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospices Civils de Lyon
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, 18 years of age or older
Recipient of a solid organ transplant
Subject affiliated with a health insurance company
Patient able to understand the objectives and risks of the research and to give a non-objection
Patient with a post-vaccination anti-Spike IgG (or RBD - Receptor Blinding Domain) titer of less than 30 BAU/ml ( (binding antibody units) measured at least 14 days after completion of an intensified vaccination regimen (at least 3 doses of mRNA vaccine) and prior to administration of anti-SARS-Cov-2 monoclonal antibodies.
Group 1 criteria: Naïve patients, never having received anti-SARS CoV2 monoclonal antibodies.
Group 2 criteria: Patients who have previously received anti-SARS Cov2 monoclonal antibodies
You may not be if
History of anaphylactic shock or known allergy to TIXAGEVIMAB/CILGAVIMAB
Known history of Covid-19 or positive Covid-19 serology within 3 months prior to inclusion
History of myocardial infarction or coronary artery disease within 3 months prior to inclusion
Contraindication to an intramuscular injection
Impossibility to give to the subject an informed information
Subject under legal protection, guardianship or curatorship
Plasmapheresis in progress or planned
Weight less than 48 kg
Patient participating in another interventional research study in progress
